Oncopeptides AB (publ) (FRA:OND)

Oncopeptides AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	116	29	65	103	62	1,148
Market Cap Growth	299.54%	-55.17%	-36.62%	67.24%	-94.64%	71.09%
Enterprise Value	116	18	54	65	-4	1,024
Last Close Price	0.42	0.12	0.46	0.72	0.50	11.18
PS Ratio	20.58	10.58	20.58	137.15	5.35	-
PB Ratio	196.63	6.17	12.76	3.89	3.00	19.99
P/TBV Ratio	196.63	6.17	12.76	3.89	3.02	20.05
EV/Sales Ratio	19.97	6.38	17.01	86.70	-	-
Debt / Equity Ratio	22.75	2.61	2.31	0.02	0.07	0.03
Asset Turnover	0.24	0.13	0.11	0.02	0.17	-
Inventory Turnover	0.21	0.78	-	-	-	-
Quick Ratio	3.27	3.74	4.26	4.22	1.78	2.44
Current Ratio	3.42	4.23	4.52	4.25	1.83	2.53
Return on Equity (ROE)	-376.73%	-512.51%	-141.91%	-133.80%	-363.13%	-232.14%
Return on Assets (ROA)	-57.86%	-73.20%	-50.66%	-52.59%	-134.59%	-97.95%
Return on Capital (ROIC)	-75.21%	-91.97%	-64.70%	-82.55%	-227.14%	-134.96%
Return on Capital Employed (ROCE)	-158.10%	-146.50%	-130.70%	-115.80%	-697.10%	-256.70%
Earnings Yield	-20.83%	-85.00%	-34.38%	-29.49%	-226.15%	-13.83%
FCF Yield	-17.76%	-77.93%	-38.59%	-36.92%	-239.82%	-11.39%
Buyback Yield / Dilution	-58.45%	-84.14%	-9.80%	-9.33%	-20.72%	-20.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.